Genomma Lab Internacional (GNMLF) to Announce Quarterly Earnings on Wednesday

Genomma Lab Internacional (OTCMKTS:GNMLF) is expected to be posting its resultson Wednesday, July 22nd. Analysts expect Genomma Lab Internacional to post earnings of $0.0268 per share and revenue of $256.24 million for the quarter.

Genomma Lab Internacional Stock Performance

OTCMKTS GNMLF opened at $0.86 on Tuesday. The company has a fifty day moving average price of $0.95 and a 200-day moving average price of $1.00. Genomma Lab Internacional has a 1 year low of $0.84 and a 1 year high of $1.17.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group assumed coverage on Genomma Lab Internacional in a research note on Sunday. They issued a “hold” rating on the stock. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company has an average rating of “Hold”.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.